Role of Resistance Testing During Oral Antiviral Therapy of Chronic Hepatitis B Uma DeviStephen Locarnini Hepatitis B: Therapeutics (P Martin, Section Editor) 26 April 2012 Pages: 55 - 64
What Should Be the Endpoints of Oral Therapy in HBeAg-positive Versus HBeAg-negative Patients with Chronic Hepatitis B Stephanos J. HadziyannisDimitrios Vassilopoulos Hepatitis B: Therapeutics (P Martin, Section Editor) 24 February 2012 Pages: 65 - 69
Adherence with Use of Oral Agents in the Treatment of Chronic Hepatitis B Maximilian Lee Hepatitis B: Therapeutics (P Martin, Section Editor) 25 February 2012 Pages: 70 - 74
Update on the Role of Quantitative HBsAg and HBeAg Monitoring during Peginterferon Therapy Rami MoucariRaymond SayeghPatrick Marcellin Hepatitis B: Therapeutics (P Martin, Section Editor) 03 March 2012 Pages: 75 - 81
Optimal Management of the Hepatitis B Patient Who Desires Pregnancy or Is Pregnant Natalie H. Bzowej Hepatitis B: Therapeutics (P Martin, Section Editor) Open access 26 May 2012 Pages: 82 - 89
Partial Response to Entecavir and Tenofovir in Naïve Patients with Chronic Hepatitis B: Clinical Relevance and Management Pietro LamperticoMauro ViganòMassimo Colombo Hepatitis B: Therapeutics (P Martin, Section Editor) 14 March 2012 Pages: 90 - 94
Update on the Management of HBV-HDV Coinfection Heiner WedemeyerSvenja HardtkeMichael P. Manns Hepatitis B: Therapeutics (P Martin, Section Editor) 25 March 2012 Pages: 95 - 101
Management of Patients with Chronic Hepatitis B Before and After Liver Transplantation: An Update Andres F. CarrionPaul MartinChristopher O’Brien Hepatitis B: Therapeutics (P Martin, Section Editor) 10 March 2012 Pages: 102 - 110
Drugs in Development for the Treatment of Chronic Hepatitis B Simone I. Strasser Hepatitis B: Therapeutics (P Martin, Section Editor) 23 March 2012 Pages: 111 - 118